{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:50:27Z","timestamp":1790268627804,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY20H160039"],"award-info":[{"award-number":["LY20H160039"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bbrc.2021.05.103","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T04:39:01Z","timestamp":1623559141000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Verticillin A increases the BIMEL\/MCL-1 ratio to overcome ABT-737-resistance in human colon cancer cells by targeting the MEK\/ERK pathway"],"prefix":"10.1016","volume":"567","author":[{"given":"Yuelin","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9048-2204","authenticated-orcid":false,"given":"Kai","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.05.103_bib1","first-page":"4548","article-title":"Chemopreventive effects of some popular phytochemicals on human colon cancer: a review","volume":"9","author":"Zhao","year":"2018","journal-title":"Food Sci. Technol. Bull. Funct. Foods"},{"key":"10.1016\/j.bbrc.2021.05.103_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/2159-8290.CD-17-0461","article-title":"Suppression of adaptive responses to targeted cancer therapy by transcriptional repression","volume":"8","author":"Rusan","year":"2018","journal-title":"Canc. Discov."},{"key":"10.1016\/j.bbrc.2021.05.103_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc2297","article-title":"Diagnosing and exploiting cancer's addiction to blocks in apoptosis","volume":"8","author":"Letai","year":"2008","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2021.05.103_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl 2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2021.05.103_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2021.05.103_bib6","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1182\/blood-2009-07-233304","article-title":"Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1","volume":"115","author":"Yecies","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2021.05.103_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/cdd.2008.137","article-title":"Bcl-2 inhibitors: small molecules with a big impact on cancer therapy","volume":"16","author":"Vogler","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2021.05.103_bib8","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1158\/1535-7163.MCT-10-0033","article-title":"Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520","volume":"9","author":"Tunquist","year":"2010","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2021.05.103_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized","volume":"10","author":"van Delft","year":"2006","journal-title":"Canc. Cell"},{"key":"10.1016\/j.bbrc.2021.05.103_bib10","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.18632\/oncotarget.7744","article-title":"Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC","volume":"7","author":"Gilormini","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2021.05.103_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ccr.2007.07.001","article-title":"BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents","volume":"12","author":"Deng","year":"2007","journal-title":"Canc. Cell"},{"key":"10.1016\/j.bbrc.2021.05.103_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/leu.2011.287","article-title":"MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1\/BIM complex","volume":"26","author":"Konopleva","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2021.05.103_bib13","doi-asserted-by":"crossref","first-page":"26481","DOI":"10.1074\/jbc.M114.569632","article-title":"B\u00a0cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins","volume":"289","author":"Renault","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.05.103_bib14","doi-asserted-by":"crossref","first-page":"O974","DOI":"10.1107\/S1600536806004284","article-title":"Verticillin chloroform solvate","volume":"62","author":"Liu","year":"2006","journal-title":"Acta Crystallogr. E"},{"key":"10.1016\/j.bbrc.2021.05.103_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ja.2012.69","article-title":"Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae","volume":"65","author":"Figueroa","year":"2012","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.bbrc.2021.05.103_bib16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10295-018-2083-8","article-title":"Media studies to enhance the production of verticillins facilitated by in situ chemical analysis","volume":"45","author":"Amrine","year":"2018","journal-title":"J.\u00a0Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2021.05.103_bib17","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.4049\/jimmunol.1402243","article-title":"H3K9 trimethylation silences fas expression to confer colon carcinoma immune escape and 5-fluorouracil chemoresistance","volume":"195","author":"Paschall","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2021.05.103_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1535-7163.MCT-19-0205","article-title":"Verticillin A causes apoptosis and reduces tumor burden in high-grade serous ovarian cancer by inducing DNA damage","volume":"19","author":"Salvi","year":"2020","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2021.05.103_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw283","article-title":"The MLL1-H3K4me3 axis-mediated PD-L1 expression and pancreatic cancer immune evasion","volume":"109","author":"Lu","year":"2017","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.bbrc.2021.05.103_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4061-y","article-title":"Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells","volume":"18","author":"Lu","year":"2018","journal-title":"BMC Canc."},{"key":"10.1016\/j.bbrc.2021.05.103_bib21","article-title":"Verticillin A inhibits leiomyosarcoma and malignant peripheral nerve sheath tumor growth via induction of apoptosis","volume":"6","author":"Zewdu","year":"2016","journal-title":"Clin. Exp. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.05.103_bib22","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.2147\/OTT.S208683","article-title":"Verticillin A suppresses HGF-induced migration and invasion via repression of the c-Met\/FAK\/Src pathway in human gastric and cervical cancer cells","volume":"12","author":"Lu","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2021.05.103_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1631\/jzus.B2000190","article-title":"Verticillin A inhibits colon cancer cell migration and invasion by targeting c-Met","volume":"21","author":"Liu","year":"2020","journal-title":"J.\u00a0Zhejiang Univ. - Sci. B"},{"key":"10.1016\/j.bbrc.2021.05.103_bib24","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1158\/0008-5472.CAN-11-1575","article-title":"Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3","volume":"71","author":"Liu","year":"2011","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2021.05.103_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.canlet.2014.03.017","article-title":"Imperatorin induces Mcl-1 degradation to cooperatively trigger Bax translocation and Bak activation to suppress drug-resistant human hepatoma","volume":"348","author":"Li","year":"2014","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2021.05.103_bib26","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1182\/blood-2004-07-2767","article-title":"Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK\/ERK pathways and activation of SEK1\/JNK","volume":"105","author":"Dai","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2021.05.103_bib27","doi-asserted-by":"crossref","first-page":"23058","DOI":"10.18632\/oncotarget.5492","article-title":"Regulation of bim in health and disease","volume":"6","author":"Sionov","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2021.05.103_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1097-2765(00)80456-6","article-title":"The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex","volume":"3","author":"Puthalakath","year":"1999","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrc.2021.05.103_bib29","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/MCB.22.11.3577-3589.2002","article-title":"Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis","volume":"22","author":"Marani","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.05.103_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1083\/jcb.200610148","article-title":"BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins","volume":"177","author":"Weber","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2021.05.103_bib31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/1878-0261.12422","article-title":"Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer","volume":"13","author":"Packer","year":"2019","journal-title":"OA Mol. Oncol."},{"key":"10.1016\/j.bbrc.2021.05.103_bib32","doi-asserted-by":"crossref","first-page":"18811","DOI":"10.1074\/jbc.M301010200","article-title":"Activation of the ERK1\/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim","volume":"278","author":"Ley","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.05.103_bib33","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/sj.cdd.4401688","article-title":"Regulatory phosphorylation of Bim: sorting out the ERK from the JNK","volume":"12","author":"Ley","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2021.05.103_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-2588-8","article-title":"Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib","volume":"11","author":"Florent","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2021.05.103_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1158\/1535-7163.MCT-16-0342","article-title":"The mTORC1\/2 inhibitor AZD8055 strengthens the efficiency of the MEK inhibitor trametinib to reduce the mcl-1\/[bim and puma] ratio and to sensitize ovarian carcinoma cells to ABT-737","volume":"16","author":"Petigny-Lechartier","year":"2017","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2021.05.103_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2010.48","article-title":"Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS","volume":"1","author":"Jiang","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2021.05.103_bib37","doi-asserted-by":"crossref","first-page":"9382","DOI":"10.1074\/jbc.M110.203638","article-title":"The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner","volume":"286","author":"Kazi","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.05.103_bib38","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1158\/0008-5472.CAN-09-0878","article-title":"Blockade of mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim","volume":"70","author":"Zhang","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2021.05.103_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s003350010242","article-title":"Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim","volume":"12","author":"Bouillet","year":"2001","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.bbrc.2021.05.103_bib40","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3892\/ijo.2014.2652","article-title":"Gossypol induces apoptosis in multiple myeloma cells by inhibition of interleukin-6 signaling and Bcl-2\/Mcl-1 pathway","volume":"45","author":"Sadahira","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2021.05.103_bib41","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1158\/1078-0432.CCR-07-0665","article-title":"Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1","volume":"13","author":"Wang","year":"2007","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2021.05.103_bib42","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1172\/JCI35437","article-title":"Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic","volume":"118","author":"Cragg","year":"2008","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21009025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21009025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:40:13Z","timestamp":1762094413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21009025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":42,"alternative-id":["S0006291X21009025"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.05.103","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Verticillin A increases the BIMEL\/MCL-1 ratio to overcome ABT-737-resistance in human colon cancer cells by targeting the MEK\/ERK pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.05.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}